Overview
The increasing prevalence of antibiotic-resistant bacteria, known as superbugs, has threatened the field of infectious disease medicine over most of the past century. Antimicrobial peptides, a crucial part of innate immunity that exists in most living organisms, have become a central pillar for the next generation of medical challenges for infectious diseases, cancer, and other health problems. The development of new antimicrobial peptides to tackle ongoing superbug infections, cancer and other diseases is a fast-growing research area for chemistry, medical physics, biological science, food and agricultural science and different disciplines of medicine. This volume discusses the basic science behind potential pharmacological agents, which is necessary to understand how these peptides can be used in our daily lives. The book provides a foundation for a wide variety of antimicrobial peptide-based therapeutic approaches, which is invaluable for established scientists, junior researchers, and students involved in basic science, material science, the medical field and different disciplines of engineering. It contains nine chapters written by world leaders in this area, covering basic science and possible therapeutic applications with immense societal implications. Antimicrobial peptides are an exciting new therapeutic agent with promising applications for a wide variety of illnesses.
Full Product Details
Author: Dr Paresh Chandra Ray
Publisher: Nova Science Publishers Inc
Imprint: Nova Science Publishers Inc
ISBN: 9781685070052
ISBN 10: 1685070051
Pages: 238
Publication Date: 01 November 2021
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Active
Availability: Available To Order
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.
Author Information
Dr Paresh C Ray, Professor of Chemistry at Jackson State University. His research group is heavily involved in cancer nanotechnology research that include development of new assay for CTCs detection from blood, exploring new chemical strategies for the multi-photon imaging and multimodal therapy of cancer cell, designing multifunctional nanomaterial for developing nanomedicine, and enhancing our understanding of biomolecular interaction with nanosurface. He has been author/co-author for over 160 peer-reviewed publications in international and national renowned journals. His group's work has been widely cited with h-index 49. He holds several US pending patent. His research has been funded by National Science Foundation, National Institute of Health, Army Research Office, Army Research Lab, Universal Technology Corporation.
